Loading…
Modulation of Locomotor Activity by Multiple 5-HT and Dopaminergic Receptor Subtypes in the Neonatal Mouse Spinal Cord
Calgary Brain Institute, Departments of Physiology and Biophysics, Clinical Neurosciences, University of Calgary, Alberta T2N 4N1, Canada Submitted 8 December 2003; accepted in final form 10 May 2004 Recently, it has been shown that bath-applied 5-HT can elicit fictive locomotion from perinatal mous...
Saved in:
Published in: | Journal of neurophysiology 2004-09, Vol.92 (3), p.1566-1576 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Calgary Brain Institute, Departments of Physiology and Biophysics, Clinical Neurosciences, University of Calgary, Alberta T2N 4N1, Canada
Submitted 8 December 2003;
accepted in final form 10 May 2004
Recently, it has been shown that bath-applied 5-HT can elicit fictive locomotion from perinatal mouse preparations. Since 5-HT acts on multiple receptor subtypes, the focus of this study was to examine which receptor families contribute to the genesis and modulation of locomotor activity. Blockade of 5-HT 2 (ketanserin or N -desmethylclozapine) or 5-HT 7 receptors (SB-269970) could reversibly block or modulate the locomotor-like pattern. A 5-HT 2 agonist ( -methyl-5-HT) was shown to be capable of activating the rhythm. Bath application of 5-HT 7 agonists (5-CT) generally led to a tonic increase in neurogram discharge, accompanied by bouts of rhythmic activity. Blockade of dopaminergic receptors {D 1 [ R -(+)-SCH-23390 or LE 300]/D 2 [(±)-sulpiride or L-741,626] } could reversibly disrupt the rhythm and most effectively did so when the D 1 and D 2 antagonists were added together. Conversely, 5-HT 2 and D 1 /D 2 agonists can interact to evoke locomotor activity. Overall, our data show that, in the neonatal mouse preparation, 5-HT evoked locomotion is partly dependent on activation of 5-HT 2 , 5-HT 7 , and dopaminergic receptor subtypes.
Address for reprint requests and other correspondence: P. J. Whelan, Calgary Brain Institute, Dept. of Physiology and Biophysics and Clinical Neurosciences, 3330 Hospital Dr. NW, Calgary AB T2N 4N1, Canada (E-mail: whelan{at}ucalgary.ca ). |
---|---|
ISSN: | 0022-3077 1522-1598 |
DOI: | 10.1152/jn.01181.2003 |